Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:affects |
sympathetic nervous system
|
| gptkbp:cause |
increased heart rate
vasoconstriction increased blood pressure bronchodilation |
| gptkbp:contraindication |
patients with certain arrhythmias
patients with severe hypertension |
| https://www.w3.org/2000/01/rdf-schema#label |
sympathomimetics
|
| gptkbp:includes |
gptkb:phenylephrine
gptkb:albuterol gptkb:pseudoephedrine dopamine norepinephrine epinephrine |
| gptkbp:mechanismOfAction |
stimulate adrenergic receptors
|
| gptkbp:opposedBy |
sympatholytics
|
| gptkbp:relatedTo |
adrenergic agonists
|
| gptkbp:sideEffect |
anxiety
hypertension insomnia tachycardia |
| gptkbp:SIM |
effects of endogenous catecholamines
|
| gptkbp:subclassOf |
direct-acting sympathomimetics
indirect-acting sympathomimetics |
| gptkbp:usedFor |
treatment of asthma
nasal decongestion treatment of anaphylaxis |
| gptkbp:bfsParent |
gptkb:procarbazine
gptkb:Tranylcypromine gptkb:isocarboxazid gptkb:phenelzine gptkb:tranylcypromine |
| gptkbp:bfsLayer |
7
|